• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

ESCEO-IOF Pierre Meunier Young Scientist Award presented to Dr. Emmanuel Biver

Bioengineer by Bioengineer
April 24, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Emmanuel Biver MD, PhD, of the Division of Bone Diseases Geneva University Hospitals and Faculty of Medicine has been presented with the 2018 ESCEO-IOF Pierre Meunier Young Scientist Award. The joint award of the European Society for Clinical & Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) was awarded on April 22nd, at the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases, held in Kraków, Poland.

The Award recognizes a young investigator who has demonstrated outstanding scientific merit early in his or her career, prior to reaching a prominent academic position, and who is expected to be a future thought-leader in the musculoskeletal field.

Dr Biver completed medical training and specialization in rheumatology at the University of Lille 2, France. He obtained a PhD in medical sciences based on preclinical research on the regulation of signaling pathways in bone cells. He is currently consultant and in charge of clinical and translational research in the department of Bone Diseases at the University Hospital of Geneva, Switzerland. Dr Biver is the coordinator of the Geneva Retirees Cohort (GERICO), an ongoing prospective cohort investigating the determinants of bone fragility and sarcopenia with ageing. His specific interests are in the impact of nutrition or chronic metabolic or inflammatory conditions on bone microstructure and fracture risk.

###

World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Kraków 2018)

Held jointly by IOF and ESCEO, the Congress took place in Kraków, Poland, from April 19-22, 2018. WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of musculoskeletal disorders, including sarcopenia and frailty. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 240 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. http://www.iofbonehealth.org http://www.facebook.com/ @iofbonehealth

About ESCEO

The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive

Media Contact

L. Misteli
[email protected]
@iofbonehealth

http://www.iofbonehealth.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Personalized Guide to Understanding and Reducing Chemicals

February 7, 2026

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

February 7, 2026

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

February 7, 2026

Boosting Remote Healthcare: Stepped-Wedge Trial Insights

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Personalized Guide to Understanding and Reducing Chemicals

Inflammasome Protein ASC Drives Pancreatic Cancer Metabolism

Phage-Antibiotic Combo Beats Resistant Peritoneal Infection

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.